Our News

Published Scientific Articles

Inflammatory Mediators of Esophagitis Alter p27Kip1 Expression in Esophageal Epithelial Cells

Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma

Brk/Protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4

Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells

Concarlo in the News

US biotech start-up set to have huge impact on breast cancer treatment landscape

Concarlo: targeting proliferation and resistance in one go

Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer

Women & Wealth Magazine: 18 Women to Watch in 2018

Webinars & Talks

Concarlo is on a Mission to Rid the World of Metastatic Breast Cancer

Opportunity to Join the Fight Against Metastatic Breast Cancer

LabOps: Changing Outcomes for Drug-Resistant Patients with Stacy Blain, Founder, and CSO at Concarlo Therapeutics

Beyond Biotech podcast 24: Concarlo Therapeutics


“The reward for work well done is the opportunity to do more”

—Jonas Salk

RESI’s Innovator’s Pitch Challenge Winner

Princeton University Women’s Showcase

The 50 Most admired companies: CIO Bio

Top 100 entreprenuers: Alumni List

Top Biotech Startup 2022
Awarded by: Life Sciences Review